Modeling SARS-CoV-2 infection in a human alveolus microphysiological system
2024

Modeling SARS-CoV-2 Infection in a Human Alveolus Microphysiological System

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ĺ uligoj Tanja, Coombes Naomi S., Booth Catherine, Savva George M., Bewley Kevin R., Funnell Simon G.P., Juge Nathalie

Primary Institution: Quadram Institute Bioscience

Hypothesis

Can a human alveolus microphysiological system effectively model SARS-CoV-2 infection?

Conclusion

The human alveolus microphysiological system successfully models SARS-CoV-2 infection and its effects on lung cells.

Supporting Evidence

  • SARS-CoV-2 infection caused significant morphological changes in alveolar epithelial cells.
  • The model demonstrated increased viral replication within 48 hours post-infection.
  • Significant increases in cytokines IP-10 and TRAIL were observed in infected cells.

Takeaway

Scientists created a tiny lung model to study how the COVID-19 virus infects lung cells, helping us understand the disease better.

Methodology

The study used a microphysiological system with primary human alveolar epithelial and endothelial cells to model SARS-CoV-2 infection under breathing-like conditions.

Limitations

The model lacks immune cells, which may affect the immune response observed.

Statistical Information

P-Value

0.094

Confidence Interval

95%

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1099/acmi.0.000814.v3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication